Q757H2
Gene name |
CSR1 (AER041W) |
Protein name |
Phosphatidylinositol transfer protein CSR1 |
Names |
|
Species |
Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii) |
KEGG Pathway |
ago:AGOS_AER041W |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q757H2
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q757H2-F1 | Predicted | AlphaFoldDB |
No variants for Q757H2
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q757H2 | |||||
No associated diseases with Q757H2
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| endosome | A vacuole to which materials ingested by endocytosis are delivered. |
| lipid droplet | An intracellular non-membrane-bounded organelle comprising a matrix of coalesced lipids surrounded by a phospholipid monolayer. May include associated proteins. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| phosphatidylinositol transfer activity | Removes phosphatidylinositol from a membrane or a monolayer lipid particle, transports it through the aqueous phase while protected in a hydrophobic pocket, and brings it to an acceptor membrane or lipid particle. |
6 GO annotations of biological process
| Name | Definition |
|---|---|
| Golgi to plasma membrane protein transport | The directed movement of proteins from the Golgi to the plasma membrane in transport vesicles that move from the trans-Golgi network to the plasma membrane. |
| negative regulation of fatty acid biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids. |
| negative regulation of phosphatidylglycerol biosynthetic process | Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylglycerol biosynthetic process. |
| phosphatidylinositol metabolic process | The chemical reactions and pathways involving phosphatidylinositol, any glycophospholipid in which a sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol. |
| phospholipid catabolic process | The chemical reactions and pathways resulting in the breakdown of phospholipids, any lipid containing phosphoric acid as a mono- or diester. |
| positive regulation of phosphatidylcholine biosynthetic process | Any process that activates or increases the frequency, rate or extent of phosphatidylcholine biosynthetic process. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MTQTAAPGRV | QTLTKEQEKV | LKQVWVHLFQ | FWGIDVDGSA | VLTAKEPEPA | APSGKGRKLL |
| 70 | 80 | 90 | 100 | 110 | 120 |
| GLFGKRKDAT | GAARKESNGK | AAAKVYDAEK | VEDSDAEKEK | PTPQKVEGLE | EMYELLKELD |
| 130 | 140 | 150 | 160 | 170 | 180 |
| GAAVSKEFWS | MLRCDYPDNL | LLRFVRARKW | DINKAMIMMA | HSLRWRLNEG | KPEDIVFGGE |
| 190 | 200 | 210 | 220 | 230 | 240 |
| RGAQKADKKG | IVKQLELGKA | TVRGFDKNGC | PIVYVRPRLH | HAADQTEAET | SEYSLLIIEQ |
| 250 | 260 | 270 | 280 | 290 | 300 |
| ARLFLKEPCD | TATILFDLSG | FSMANMDYAP | VKFLITCFEA | HYPECLGKLF | IHKAPWIFPP |
| 310 | 320 | 330 | 340 | 350 | 360 |
| IWNIIKNWLD | PVVAAKIAFT | KTAADLEEFI | PAEQIPLELG | GKDEYNFDGF | VMPDGSADTK |
| 370 | 380 | 390 | 400 | 410 | 420 |
| LSDEKGKAAV | LEEREAIIKR | FIDATISWIE | STSDEESAKW | LEKKIDLSKE | LSENYSKLDP |
| 430 | |||||
| YIRSRSFYDV | NGTLKV |